GDNF treatment in Parkinson's disease: time for controlled clinical trials?

Patrik Brundin

doi:10.1093/brain/awf217

GDNF treatment in Parkinson's disease: time for controlled clinical trials?

Patrik Brundin

Department of Experimental Medical Science

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2149-2151
Journal	Brain
Volume	125
Issue number	10
DOIs	https://doi.org/10.1093/brain/awf217
Publication status	Published - 2002

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Neuronal Survival (013212041)

Subject classification (UKÄ)

Neurology

Access to Document

10.1093/brain/awf217

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12244075&dopt=Abstract

Cite this

@article{63b40313d07e47c48bd1e369d2196e10,

title = "GDNF treatment in Parkinson's disease: time for controlled clinical trials?",

author = "Patrik Brundin",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Neuronal Survival (013212041)",

year = "2002",

doi = "10.1093/brain/awf217",

language = "English",

volume = "125",

pages = "2149--2151",

journal = "Brain",

issn = "1460-2156",